- Home
- / GSK
GSK
- Volume of Medicines Produced1.7 BFY, 2021
- Revenue£34.1 BFY, 2021
- Market Capitalization£68.9 B2022-08-01
GSK Summary
Overview
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company develops vaccines against infectious diseases and provides a portfolio of medicines in respiratory, HIV, immuno-inflammation, and oncology. GSK combines science and consumer insights aiming to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy relief, digestive health, and vitamins, minerals, and supplements.
| Type | Public | |
| Founded | 2000 | |
| HQ | Brentford, GB | Map |
| Website | gsk.com | |
| Employee Ratings |   | |
| Overall Culture | A | More |
Locations
Table of Contents
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Key People/Management at GSK
GSK Office Locations
GSK has offices in Brentford, Philadelphia, Boumerdes, San Fernando and in 88 other locations
GSK Financials and Metrics
GSK Revenue
GSK's revenue was reported to be £34.11 b in FY, 2021
GBP
| Revenue (Q2, 2022) | £9.45 b |
| Gross profit (Q2, 2022) | £8.53 b |
| Gross profit margin (Q2, 2022), % | 90.2% |
| Net income (Q2, 2022) | £975 m |
| EBITDA (Q2, 2022) | £6.32 b |
| EBIT (Q2, 2022) | £1.42 b |
| Market capitalization (01-Aug-2022) | £68.89 b |
| Closing stock price(01-Aug-2022) | £16.94 |
| Cash (30-Jun-2022) | £6.47 b |
| EV | $84.54 b |
GSK's current market capitalization is £68.9 b.
| USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.7 b | 7.8 b | 9.4 b | 9.1 b | 7.6 b | 8.6 b | 7.4 b | 8.1 b | 9.1 b | 9.8 b | 9.5 b |
| Cost of goods sold | 2.7 b | 2.6 b | 3.2 b | 3.2 b | 2.4 b | 2.9 b | 2.5 b | 2.6 b | 2.9 b | 3.7 b | (572 m) |
| Gross profit | 4.9 b | 5.2 b | 6.1 b | 5.9 b | 5.2 b | 5.8 b | 4.9 b | 5.5 b | 6.2 b | 6.1 b | 8.5 b |
| Gross profit Margin, % | 64% | 66% | 65% | 65% | 68% | 67% | 67% | 68% | 68% | 62% | 90% |
| GBP | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | 4.1 b | 4.1 b | 4.3 b | 4.8 b | 8.2 b | 4.3 b | 4.8 b | 3.5 b | 3.5 b | 11 b | 6.5 b |
| Accounts Receivable | 6.6 b | 6.9 b | 8.2 b | 8.5 b | 7.2 b | 7.9 b | 6.5 b | 6.9 b | 7.7 b | 8.3 b | 6.5 b |
| Prepaid Expenses | 413 m | ||||||||||
| Inventories | 5.7 b | 6 b | 6.8 b | 6 b | 6.4 b | 6.4 b | 6.2 b | 6.3 b | 6.2 b | 6 b | 4.7 b |
GBP
Q2, 2022
| EV/EBITDA | 16.7 x |
| EV/EBIT | 74.5 x |
| EV/CFO | 25.2 x |
| Debt/Equity | 1.0 x |
| Debt/Assets | 0.2 x |
| Financial Leverage | 3.9 x |
Revenue Breakdown
GSK revenue breakdown by business segment: 28.2% from Consumer Healthcare, 52.0% from Global Pharmaceuticals and 19.9% from Vaccines
GSK revenue breakdown by geographic segment: 23.0% from Europe, 32.8% from International and 44.2% from US
GSK Operating Metrics
GSK's Vaccines was reported to be 767 m in FY, 2021.
GSK Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Sierra Oncology | April 13, 2022 | $1.9 b |
| Pfizer Biotech Corporation Taiwan | September 28, 2020 | £129 m |
| Sitari Pharmaceuticals | September 12, 2019 | |
| TESARO | December 04, 2018 | $5.1 b |
| GlycoVaxyn | February 11, 2015 | $190 m |
| Okairos AG | May 29, 2013 | $325 m |
| Human Genome Sciences | August 03, 2012 | $3 b |
| CellZome | May 15, 2012 | £61 m |
| MaxiNutrition | December 13, 2010 | £162 m |
| Nanjing MeiRui Pharma Co., Ltd. | December 07, 2010 | $70 m |
Human Capital Metrics
Source: uploads5.craft.co, www.gsk.com, uploads4.craft.co
GSK Hiring Categories
GSK Median Salaries
Source: 9 public H-1B filings from GSK
GSK Cybersecurity Score
GSK Environment, Social & Governance (ESG) Ratings
Market Position of GSK
GSK Website Traffic
Total Visits per monthSimilarWeb
Twitter Engagement Stats for @gsk
13.31 k
Tweets
719
Following
238.7 k
Followers
42
Tweets last 30 days
17.3
Avg. likes per Tweet
81%
Tweets with engagement
GSK Technology Stack![BuildWith Logo]()
ads
27 products used
- Adobe Audience Manager
- AdRoll
- AppNexus
- AppNexus Segment Pixel
- Bizo
- BlueKai
- DeepIntent
- DemDex
- DoubleClick Bid Manager
- DoubleClick.Net
- Ezakus
- Facebook Custom Audiences
- Facebook Exchange FBX
- Google Adsense
- Google AdSense Custom Search Ads
- Google Remarketing
- IponWeb BidSwitch
- JW Player Tracking
- Openads/OpenX
- Outbrain
- Pubmatic
- Rocket Fuel
- Rubicon Project
- The Trade Desk
- travel audience
- Twitter Ads
- Yahoo Small Business
analytics
46 products used
- accessiBe
- Adobe Analytics
- Adobe CQ Analytics
- Adobe Experience Platform Identity Service
- Adobe Marketing Cloud
- Adobe Target Standard
- Adobe Target v2.x
- Akamai mPulse
- Amazon Advertising Sizmek Ad Suite
- Bing Universal Event Tracking
- Bizo Insights
- Clicktools
- Decibel Insight
- DoubleClick Floodlight
- Everest Technologies
- Facebook Domain Insights
- Facebook Pixel
- Facebook Signal
- Global Site Tag
- Google Analytics
- Google Analytics Classic
- Google Analytics Enhanced Link Attribution
- Google Analytics Event Tracking
- Google Analytics IP Anonymization
- Google Conversion Tracking
- Google Universal Analytics
- Hotjar
- LinkedIn Insights
- LiveRamp
- Marketo
- MediaMath
- New Relic
- Omniture Adobe Test and Target
- Omniture SiteCatalyst
- Poppulo
- Quantcast Measurement
- Quantum Metric
- Rapleaf
- Salesforce
- Segment
- Tealium UTAG
- Twitter Analytics
- Twitter Conversion Tracking
- Twitter Website Universal Tag
- Yahoo Dot
- Yahoo Web Analytics
CDN
15 products used
- AJAX Libraries API
- Akamai
- Amazon S3
- Azure Edge
- BootstrapCDN
- CDN JS
- CloudFront
- Cloudinary
- Content Delivery Network
- GStatic Google Static Content
- Microsoft Azure Blob Storage
- Microsoft Azure CDN
- RawGit
- Twitter CDN
- Yahoo Image CDN
cdns
3 products used
- Akamai Edge
- Amazon CloudFront
- Amazon S3 CDN
GSK Company Culture![CultureAndCompensation Logo]()
Overall Culture
A
77/100
CEO Rating
A+
80/100
Compensation
A-
76/100
Diversity
B+
75/100
GSK News and Updates
Jul 29, 2022
$1.7 Billion Worldwide Pharmaceutical Drug Delivery Industry to 2027 - Featuring GSK, Johnson & Johnson, Novartis and Pfizer Among OthersJul 27, 2022
Dow Jones Newswires: GSK second quarter profit dips to $1.3 billion but raises outlook for rest of year
British pharmaceutical major posted operating profit of £1.08 billion pounds ($1.30 billion) for the period, down from £1.28 billion the year prior.Jul 26, 2022
GSK Pharma Q1 Review - In-Line; Focus Remain On Rx Growth: Centrum Broking
GSK Pharma Q1 Review - In-Line; Focus Remain On Rx Growth: Centrum BrokingJul 26, 2022
UAE Oral Care Markets Report 2022 Featuring 3M Medical UAE, P&G UAE, GSK UAE, Colgate Palmolive UAE, Philips UAE, Ansar Harford FZC, & Biofresh Healthcare ProductsJul 26, 2022
GSK Pharma Q1 Review - Pain, Vaccine Therapies Hinder Revenue Growth: Motilal Oswal
GSK Pharma Q1 Review - Pain, Vaccine Therapies Hinder Revenue Growth: Motilal OswalJul 18, 2022
GSK spinoff Haleon starts trading in largest European listing in a decade
Europe's biggest listing in a decade, Haleon, started trading on the London Stock Exchange on Monday. Haleon in the consumer-health business spinoff of GSK . The combined price of Haleon, 331.7 pence, and the remaining GSK,
1,383.40 pence, of 1715.10 pence, compares to GSK's Friday close of 1,719.20 pence. Haleon will start trading on a when-issued basis on the New York Stock Exchange on Monday, with full trading slated for Friday.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
GSK Blogs
Jun 12, 2020
ViiV Healthcare announces US FDA approval of the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIVPress release
Jun 04, 2020
GSK announces new data presentations from the DREAMM programme exploring investigational belantamab mafodotin in patients with relapsed/refractory multiple myeloma16 presentations, including new analyses from the pivotal DREAMM-2 study and initial results from the DREAMM-4 study
May 28, 2020
GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborationsAnnouncement follows completion of global manufacturing review and decision to invest in expanded manufacturing capacity
May 27, 2020
DREAMM-2 and DREAMM-6 data at ASCO reinforce the potential of GSK’s investigational belantamab mafodotin in patients with relapsed/refractory multiple myelomaDREAMM-2 and DREAMM-6 data at ASCO reinforce the potential of GSK’s investigational belantamab mafodotin
May 27, 2020
FDA grants priority review of Nucala for patients with Hypereosinophilic Syndrome (HES)An approval would give Nucala a third indication in an eosinophil-driven disease
May 21, 2020
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolioGSK and Samsung Biologics have entered a partnership
You may also be interested in Related companies
Alfasigma
HQ
Bologna, IT
Employees
1699 ↑ 1% increase
Alfasigma is a pharmaceutical company providing prescription and over-the-counter drugs.
View company
EFFIK International
HQ
Anderlecht, BE
Employees
222 ↑ 2% increase
EFFIK International is a pharmaceutical laboratory.
View company
Ozon Pharm
HQ
Zhigulevsk, RU
Employees
223
Ozon Pharm is a pharmaceutical company that manufactures medicines.
View company
- When was GSK founded?
- GSK was founded in 2000.
- Who are GSK key executives?
- GSK's key executives are Emma Walmsley, Iain MacKay and Hal Barron.
- How many employees does GSK have?
- GSK has 90,096 employees.
- What is GSK revenue?
- Latest GSK annual revenue is £34.11 b.
- What is GSK revenue per employee?
- Latest GSK revenue per employee is £378.64 k.
- Who are GSK competitors?
- Competitors of GSK include Pfizer, Merck and Johnson & Johnson.
- Where is GSK headquarters?
- GSK headquarters is located at 980 Great West Rd, Brentford.
- Where are GSK offices?
- GSK has offices in Brentford, Philadelphia, Boumerdes, San Fernando and 88 other locations
- How many offices does GSK have?
- GSK has 99 offices.
Craft real-time company insights
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies